M7T Shares Mach7 Technologies Limited
ASX · ASXLast in our picks 2026-10-19 — not in the current list; analysis below is from that screen
Interactive entertainment pipeline offers asymmetric upside, but small-cap liquidity and execution risks are significant.
Future value: $0.40 (+81.51%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Speculative catalyst with limited liquidity
- ▾Below 50-day MA (-13.18%)
- ▾Near 52-week low (2.1% of range)
- ▸~82% upside to price target
Is M7T a buy right now?
Trend: M7T is trading above the 50-day average (+0.00%), RSI 26 — oversold territory, with a 3-month return of -13.79%.
Valuation & quality: Mach7 Technologies Limited trades on forward P/E -12.9, PEG 1.12, price-to-book 1.70; fundamentals show net margin -31.9%, return on equity -22.3%, revenue growth -10.9% year on year.
Analyst consensus: 2 analysts have a mean 12-month price target of A$0.40 (+59.7% vs the last close; range A$0.32 – A$0.48), consensus rating “none”.
Our screen: ACCUMULATE (score 1) — Interactive entertainment pipeline offers asymmetric upside, but small-cap liquidity and execution risks are significant.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -2.90% | -24.20% | +32.00% | -12.10% | +0.00% | -3.40% | -17.90% | +8.70% |
Fundamentals
Analyst price target
Technical signals
About Mach7 Technologies Limited
Mach7 Technologies Limited develops and commercializes medical imaging and data management software solutions for healthcare organizations in North America, the Asia Pacific, the Middle East, Europe, and internationally.
Sector: Healthcare · Industry: Health Information Services · Australia · Website
Related Communication Services picks
Browse: all ASX stocks · Communication Services picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.